Nautilus Biotechnology, Inc.
NAUTNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $330.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.84$4.31
- Volume (live)
- -
- Avg. volume (3M)
- 7.84M
Nautilus Biotechnology (NAUT) Stock Price & Financial Analysis
Nautilus Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.54 - $2.86 |
|---|---|
| 52-Week High | $4.31 |
| 52-Week Low | $0.84 |
| Open | $2.72 |
| Volume (last close) | 6.91M |
| Average Volume (3M) | 7.84M |
| Revenue (TTM) | 10.00K |
|---|---|
| Net Income (TTM) | -56.52M |
| Free Cash Flow (TTM) | -51.86M |
| EPS (TTM) | −$0.45 |
| Profit Margin | -565210.00% |
| Operating Margin | -627830.00% |
| Return on Equity (ROE) | -43.11% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 330.55M |
|---|---|
| Shares Outstanding | 127.14M |
| Price to Sales (P/S) | 33055.29 |
| Price to Book (P/B) | 2.52 |
| EV/EBITDA | -6.26 |
| 50-Day MA | $1.27 |
|---|---|
| 200-Day MA | $2.08 |
| 1-Year Change | +79.31% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Nautilus Biotechnology at a Glance
As of the Oct 22, 2026 close, Nautilus Biotechnology (NAUT) has a market capitalization of $330.55M. The stock trades at 33055.3× sales. Over the trailing twelve months it lost $56.52M on revenue of $10.00K and burned $51.86M of free cash flow.
As of its latest reported balance sheet, it holds $13.17M in cash and securities against $27.82M of debt, a net debt position of $14.65M.
Nautilus Biotechnology does not currently pay a dividend.
The share price is up 79.3% over the past year. At $2.60 (the Oct 22, 2026 close) it sits within its 52-week range of $0.84 to $4.31, above its 200-day moving average of $2.08.
Frequently Asked Questions About Nautilus Biotechnology
What is the current stock price for NAUT?
As of the Oct 22, 2026 close, NAUT stock trades at $2.60. The 52-week range is $0.84–$4.31, with a day range of $2.54–$2.86.
What is the P/E ratio for NAUT?
The P/E ratio (Price-to-Earnings) for NAUT is shown in the Key Statistics section. This valuation metric helps compare Nautilus Biotechnology, Inc. to industry peers.
Does NAUT pay dividends?
Nautilus Biotechnology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NAUT?
Analyst ratings and recommendations for NAUT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NAUT?
As of the Oct 22, 2026 close, Nautilus Biotechnology's market capitalization is $330.6M, classifying it as a small-cap company. Nautilus Biotechnology operates in the Healthcare sector within the Biotechnology industry.